APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Protein Therapeutics

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Selected research

Market Structure

Global Plasma Protein Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchPlasma Protein Therapeutics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Protein Therapeutics Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Plasma Protein Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Protein Therapeutics Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Protein Therapeutics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.

This report provides an overview of the global Plasma Protein Therapeutics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Plasma Protein Therapeutics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasma Protein Therapeutics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plasma Protein Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Plasma Protein Therapeutics Segment by Company

Shire (Baxalta)

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Kamada

Plasma Protein Therapeutics Segment by Type

Coagulation Factor

Immune Globulin

Albumin

Others

Plasma Protein Therapeutics Segment by Application

Hemophilia

PID

Others

Plasma Protein Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Protein Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Protein Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Protein Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plasma Protein Therapeutics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plasma Protein Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Plasma Protein Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Plasma Protein Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Plasma Protein Therapeutics Industry Trends Table 2. Plasma Protein Therapeutics Industry Drivers Table 3. Plasma Protein Therapeutics Industry Opportunities and Challenges Table 4. Plasma Protein Therapeutics Industry Restraints Table 5. Global Plasma Protein Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Plasma Protein Therapeutics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Plasma Protein Therapeutics Sales Market Share by Manufacturers Table 9. Global Plasma Protein Therapeutics Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Plasma Protein Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Plasma Protein Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Plasma Protein Therapeutics Manufacturers, Product Type & Application Table 13. Global Plasma Protein Therapeutics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Plasma Protein Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Coagulation Factor Table 17. Major Manufacturers of Immune Globulin Table 18. Major Manufacturers of Albumin Table 19. Major Manufacturers of Others Table 20. Global Plasma Protein Therapeutics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Plasma Protein Therapeutics Sales by Type (2021-2026) & (K Units) Table 22. Global Plasma Protein Therapeutics Sales by Type (2027-2032) & (K Units) Table 23. Global Plasma Protein Therapeutics Sales Market Share by Type (2021-2026) Table 24. Global Plasma Protein Therapeutics Sales Market Share by Type (2027-2032) Table 25. Global Plasma Protein Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Plasma Protein Therapeutics Revenue by Type (2021-2026) & (K Units) Table 27. Global Plasma Protein Therapeutics Revenue by Type (2027-2032) & (K Units) Table 28. Global Plasma Protein Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Plasma Protein Therapeutics Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hemophilia Table 31. Major Manufacturers of PID Table 32. Major Manufacturers of Others Table 33. Global Plasma Protein Therapeutics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Plasma Protein Therapeutics Sales by Application (2021-2026) & (K Units) Table 35. Global Plasma Protein Therapeutics Sales by Application (2027-2032) & (K Units) Table 36. Global Plasma Protein Therapeutics Sales Market Share by Application (2021-2026) Table 37. Global Plasma Protein Therapeutics Sales Market Share by Application (2027-2032) Table 38. Global Plasma Protein Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Plasma Protein Therapeutics Revenue by Application (2021-2026) & (K Units) Table 40. Global Plasma Protein Therapeutics Revenue by Application (2027-2032) & (K Units) Table 41. Global Plasma Protein Therapeutics Revenue Market Share by Application (2021-2026) Table 42. Global Plasma Protein Therapeutics Revenue Market Share by Application (2027-2032) Table 43. Global Plasma Protein Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Plasma Protein Therapeutics Sales by Region (2021-2026) & (K Units) Table 45. Global Plasma Protein Therapeutics Sales Market Share by Region (2021-2026) Table 46. Global Plasma Protein Therapeutics Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Plasma Protein Therapeutics Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Plasma Protein Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Plasma Protein Therapeutics Sales by Country (2021-2026) & (K Units) Table 50. North America Plasma Protein Therapeutics Sales by Country (2027-2032) & (K Units) Table 51. Europe Plasma Protein Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Plasma Protein Therapeutics Sales by Country (2021-2026) & (K Units) Table 53. Europe Plasma Protein Therapeutics Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Plasma Protein Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Plasma Protein Therapeutics Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Plasma Protein Therapeutics Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Plasma Protein Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Plasma Protein Therapeutics Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Plasma Protein Therapeutics Sales by Country (2027-2032) & (K Units) Table 60. Global Plasma Protein Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Plasma Protein Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Plasma Protein Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Plasma Protein Therapeutics Revenue Market Share by Region (2021-2026) Table 64. Global Plasma Protein Therapeutics Revenue Market Share by Region (2027-2032) Table 65. Shire (Baxalta) Company Information Table 66. Shire (Baxalta) Business Overview Table 67. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio Table 69. Shire (Baxalta) Recent Development Table 70. CSL Company Information Table 71. CSL Business Overview Table 72. CSL Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. CSL Plasma Protein Therapeutics Product Portfolio Table 74. CSL Recent Development Table 75. Grifols Company Information Table 76. Grifols Business Overview Table 77. Grifols Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Grifols Plasma Protein Therapeutics Product Portfolio Table 79. Grifols Recent Development Table 80. Octapharma Company Information Table 81. Octapharma Business Overview Table 82. Octapharma Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Octapharma Plasma Protein Therapeutics Product Portfolio Table 84. Octapharma Recent Development Table 85. Kedrion Company Information Table 86. Kedrion Business Overview Table 87. Kedrion Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Kedrion Plasma Protein Therapeutics Product Portfolio Table 89. Kedrion Recent Development Table 90. LFB Group Company Information Table 91. LFB Group Business Overview Table 92. LFB Group Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. LFB Group Plasma Protein Therapeutics Product Portfolio Table 94. LFB Group Recent Development Table 95. Biotest Company Information Table 96. Biotest Business Overview Table 97. Biotest Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Biotest Plasma Protein Therapeutics Product Portfolio Table 99. Biotest Recent Development Table 100. BPL Company Information Table 101. BPL Business Overview Table 102. BPL Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. BPL Plasma Protein Therapeutics Product Portfolio Table 104. BPL Recent Development Table 105. RAAS Company Information Table 106. RAAS Business Overview Table 107. RAAS Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. RAAS Plasma Protein Therapeutics Product Portfolio Table 109. RAAS Recent Development Table 110. CBPO Company Information Table 111. CBPO Business Overview Table 112. CBPO Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. CBPO Plasma Protein Therapeutics Product Portfolio Table 114. CBPO Recent Development Table 115. Hualan Bio Company Information Table 116. Hualan Bio Business Overview Table 117. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Hualan Bio Plasma Protein Therapeutics Product Portfolio Table 119. Hualan Bio Recent Development Table 120. Kamada Company Information Table 121. Kamada Business Overview Table 122. Kamada Plasma Protein Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Kamada Plasma Protein Therapeutics Product Portfolio Table 124. Kamada Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Plasma Protein Therapeutics Distributors List Table 128. Plasma Protein Therapeutics Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Plasma Protein Therapeutics Product Image Figure 2. Global Plasma Protein Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Protein Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Protein Therapeutics Sales (2021-2032) & (K Units) Figure 5. Global Plasma Protein Therapeutics Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Plasma Protein Therapeutics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Coagulation Factor Image Figure 9. Immune Globulin Image Figure 10. Albumin Image Figure 11. Others Image Figure 12. Global Plasma Protein Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Plasma Protein Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Plasma Protein Therapeutics Sales Market Share by Type (2021-2032) Figure 15. Global Plasma Protein Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Plasma Protein Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Plasma Protein Therapeutics Revenue Market Share by Type (2021-2032) Figure 18. Hemophilia Image Figure 19. PID Image Figure 20. Others Image Figure 21. Global Plasma Protein Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Plasma Protein Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Plasma Protein Therapeutics Sales Market Share by Application (2021-2032) Figure 24. Global Plasma Protein Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Plasma Protein Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Plasma Protein Therapeutics Revenue Market Share by Application (2021-2032) Figure 27. North America Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Plasma Protein Therapeutics Sales Market Share by Country (2021-2032) Figure 29. U.S. Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Plasma Protein Therapeutics Sales Market Share by Country (2021-2032) Figure 34. Germany Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Country (2021-2032) Figure 41. China Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Country (2021-2032) Figure 49. Brazil Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Plasma Protein Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Plasma Protein Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Plasma Protein Therapeutics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Plasma Protein Therapeutics Revenue (2021-2032) & (US$ Million) Figure 60. North America Plasma Protein Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Plasma Protein Therapeutics Revenue (2021-2032) & (US$ Million) Figure 62. Europe Plasma Protein Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Plasma Protein Therapeutics Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Plasma Protein Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Plasma Protein Therapeutics Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Plasma Protein Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Plasma Protein Therapeutics Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Plasma Protein Therapeutics Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factor
  • Immune Globulin
  • Albumin
  • Others
Applications
  • Hemophilia
  • PID
  • Others
Companies covered
  • Shire (Baxalta)
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Kamada

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasma Protein Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasma Protein Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Plasma Protein Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Plasma Protein Therapeutics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Plasma Protein Therapeutics Market Dynamics
  1. 2.1 Plasma Protein Therapeutics Industry Trends
  2. 2.2 Plasma Protein Therapeutics Industry Drivers
  3. 2.3 Plasma Protein Therapeutics Industry Opportunities and Challenges
  4. 2.4 Plasma Protein Therapeutics Industry Restraints
3 Plasma Protein Therapeutics Market by Manufacturers
  1. 3.1 Global Plasma Protein Therapeutics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Plasma Protein Therapeutics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Plasma Protein Therapeutics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Plasma Protein Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Plasma Protein Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Plasma Protein Therapeutics Manufacturers, Product Type & Application
  7. 3.7 Global Plasma Protein Therapeutics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Plasma Protein Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Plasma Protein Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Plasma Protein Therapeutics Tier 1, Tier 2, and Tier 3
4 Plasma Protein Therapeutics Market by Type
  1. 4.1 Plasma Protein Therapeutics Type Introduction
  2. 4.1.1 Coagulation Factor
  3. 4.1.2 Immune Globulin
  4. 4.1.3 Albumin
  5. 4.1.4 Others
  6. 4.2 Global Plasma Protein Therapeutics Sales by Type
  7. 4.2.1 Global Plasma Protein Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Plasma Protein Therapeutics Sales by Type (2021-2032)
  9. 4.2.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2021-2032)
  10. 4.3 Global Plasma Protein Therapeutics Revenue by Type
  11. 4.3.1 Global Plasma Protein Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Plasma Protein Therapeutics Revenue by Type (2021-2032)
  13. 4.3.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2021-2032)
5 Plasma Protein Therapeutics Market by Application
  1. 5.1 Plasma Protein Therapeutics Application Introduction
  2. 5.1.1 Hemophilia
  3. 5.1.2 PID
  4. 5.1.3 Others
  5. 5.2 Global Plasma Protein Therapeutics Sales by Application
  6. 5.2.1 Global Plasma Protein Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plasma Protein Therapeutics Sales by Application (2021-2032)
  8. 5.2.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Plasma Protein Therapeutics Revenue by Application
  10. 5.3.1 Global Plasma Protein Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Plasma Protein Therapeutics Revenue by Application (2021-2032)
  12. 5.3.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2021-2032)
6 Global Plasma Protein Therapeutics Sales by Region
  1. 6.1 Global Plasma Protein Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasma Protein Therapeutics Sales by Region (2021-2032)
  3. 6.2.1 Global Plasma Protein Therapeutics Sales by Region (2021-2026)
  4. 6.2.2 Global Plasma Protein Therapeutics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasma Protein Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Plasma Protein Therapeutics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Plasma Protein Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Plasma Protein Therapeutics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Plasma Protein Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Plasma Protein Therapeutics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Plasma Protein Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Plasma Protein Therapeutics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Plasma Protein Therapeutics Revenue by Region
  1. 7.1 Global Plasma Protein Therapeutics Revenue by Region
  2. 7.1.1 Global Plasma Protein Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Plasma Protein Therapeutics Revenue by Region (2021-2026)
  4. 7.1.3 Global Plasma Protein Therapeutics Revenue by Region (2027-2032)
  5. 7.1.4 Global Plasma Protein Therapeutics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Plasma Protein Therapeutics Revenue (2021-2032)
  8. 7.2.2 North America Plasma Protein Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Plasma Protein Therapeutics Revenue (2021-2032)
  11. 7.3.2 Europe Plasma Protein Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Plasma Protein Therapeutics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Plasma Protein Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Plasma Protein Therapeutics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Plasma Protein Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shire (Baxalta)
  2. 8.1.1 Shire (Baxalta) Company Information
  3. 8.1.2 Shire (Baxalta) Business Overview
  4. 8.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
  6. 8.1.5 Shire (Baxalta) Recent Developments
  7. 8.2 CSL
  8. 8.2.1 CSL Company Information
  9. 8.2.2 CSL Business Overview
  10. 8.2.3 CSL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSL Plasma Protein Therapeutics Product Portfolio
  12. 8.2.5 CSL Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Plasma Protein Therapeutics Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Plasma Protein Therapeutics Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Plasma Protein Therapeutics Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 LFB Group
  32. 8.6.1 LFB Group Company Information
  33. 8.6.2 LFB Group Business Overview
  34. 8.6.3 LFB Group Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LFB Group Plasma Protein Therapeutics Product Portfolio
  36. 8.6.5 LFB Group Recent Developments
  37. 8.7 Biotest
  38. 8.7.1 Biotest Company Information
  39. 8.7.2 Biotest Business Overview
  40. 8.7.3 Biotest Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biotest Plasma Protein Therapeutics Product Portfolio
  42. 8.7.5 Biotest Recent Developments
  43. 8.8 BPL
  44. 8.8.1 BPL Company Information
  45. 8.8.2 BPL Business Overview
  46. 8.8.3 BPL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BPL Plasma Protein Therapeutics Product Portfolio
  48. 8.8.5 BPL Recent Developments
  49. 8.9 RAAS
  50. 8.9.1 RAAS Company Information
  51. 8.9.2 RAAS Business Overview
  52. 8.9.3 RAAS Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 RAAS Plasma Protein Therapeutics Product Portfolio
  54. 8.9.5 RAAS Recent Developments
  55. 8.10 CBPO
  56. 8.10.1 CBPO Company Information
  57. 8.10.2 CBPO Business Overview
  58. 8.10.3 CBPO Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CBPO Plasma Protein Therapeutics Product Portfolio
  60. 8.10.5 CBPO Recent Developments
  61. 8.11 Hualan Bio
  62. 8.11.1 Hualan Bio Company Information
  63. 8.11.2 Hualan Bio Business Overview
  64. 8.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hualan Bio Plasma Protein Therapeutics Product Portfolio
  66. 8.11.5 Hualan Bio Recent Developments
  67. 8.12 Kamada
  68. 8.12.1 Kamada Company Information
  69. 8.12.2 Kamada Business Overview
  70. 8.12.3 Kamada Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kamada Plasma Protein Therapeutics Product Portfolio
  72. 8.12.5 Kamada Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plasma Protein Therapeutics Value Chain Analysis
  2. 9.1.1 Plasma Protein Therapeutics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plasma Protein Therapeutics Production Mode & Process
  6. 9.2 Plasma Protein Therapeutics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plasma Protein Therapeutics Distributors
  9. 9.2.3 Plasma Protein Therapeutics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst